Cooper Total Current Liabilities 2010-2024 | COO

Cooper total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Cooper total current liabilities for the quarter ending July 31, 2024 were $0.970B, a 2.43% decline year-over-year.
  • Cooper total current liabilities for 2023 were $0.969B, a 24.31% decline from 2022.
  • Cooper total current liabilities for 2022 were $1.28B, a 74.87% increase from 2021.
  • Cooper total current liabilities for 2021 were $0.732B, a 27.11% decline from 2020.
Cooper Annual Total Current Liabilities
(Millions of US $)
2023 $969
2022 $1,280
2021 $732
2020 $1,004
2019 $1,111
2018 $537
2017 $396
2016 $543
2015 $569
2014 $442
2013 $321
2012 $263
2011 $267
2010 $200
2009 $175
Cooper Quarterly Total Current Liabilities
(Millions of US $)
2024-07-31 $970
2024-04-30 $953
2024-01-31 $965
2023-10-31 $969
2023-07-31 $994
2023-04-30 $949
2023-01-31 $916
2022-10-31 $1,280
2022-07-31 $1,376
2022-04-30 $1,648
2022-01-31 $1,664
2021-10-31 $732
2021-07-31 $1,063
2021-04-30 $993
2021-01-31 $961
2020-10-31 $1,004
2020-07-31 $1,129
2020-04-30 $1,025
2020-01-31 $1,069
2019-10-31 $1,111
2019-07-31 $889
2019-04-30 $941
2019-01-31 $939
2018-10-31 $537
2018-07-31 $461
2018-04-30 $460
2018-01-31 $416
2017-10-31 $396
2017-07-31 $371
2017-04-30 $343
2017-01-31 $518
2016-10-31 $543
2016-07-31 $320
2016-04-30 $322
2016-01-31 $348
2015-10-31 $569
2015-07-31 $530
2015-04-30 $536
2015-01-31 $383
2014-10-31 $442
2014-07-31 $298
2014-04-30 $265
2014-01-31 $268
2013-10-31 $321
2013-07-31 $249
2013-04-30 $229
2013-01-31 $226
2012-10-31 $263
2012-07-31 $232
2012-04-30 $228
2012-01-31 $206
2011-10-31 $267
2011-07-31 $238
2011-04-30 $206
2011-01-31 $186
2010-10-31 $200
2010-07-31 $224
2010-04-30 $208
2010-01-31 $179
2009-10-31 $175
2009-07-31 $212
2009-04-30 $212
2009-01-31 $254
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.898B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Labcorp (LH) United States $20.088B 16.66
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49